Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Acute myeloid leukaemia (AML) is a major haematopoietic malignancy characterized by the proliferation of a malignant clone of myeloid progenitor cells. A reciprocal translocation, t(8;21)(q22;q22), observed in the leukaemic cells of approximately 40% of patients with the M2 subtype of AML disrupts both the AML1 (CBFA2) gene on chromosome 21 and the ETO (MTG8) gene on chromosome 8 (refs 3-5). A chimaeric protein is synthesized from one of the derivative chromosomes that contains the N terminus of the AML1 transcription factor, including its DNA-binding domain, fused to most of ETO, a protein of unknown function. We generated mice that mimic human t(8;21) with a "knock-in' strategy. Mice heterozygous for an AML1-ETO allele (AML1-ETO/+) die in midgestation from haemorrhaging in the central nervous system and exhibit a severe block in fetal liver haematopoiesis. This phenotype is very similar to that resulting from homozygous disruption of the AML1 (Cbfa2) or Cbfb genes, indicating that AML1-ETO blocks normal AML1 function. However, yolk sac cells from AML1-ETO/+ mice differentiated into macrophages in haematopoietic colony forming unit (CFU) assays, unlike Cbfa2-/- or Cbfb-/-cells, which form no colonies in vitro. This indicates that AML1-ETO may have other functions besides blocking wild-type AML1, a property that may be important in leukaemogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, AML1-ETO and inv (16) transgenic mice display a phenotype similar to that of AML-1 (CBF-␣)-and CBF--deficient mice, as they die during embryogenesis from central nervous system hemorrhages and exhibit severe blocks in fetal liver hematopoiesis (6,52,69,70,74).”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [74]
In the citing paper
“These results were corroborated by the generation of AML-1-ETO”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [74]
In the citing paper
“RUNX1 is frequently inactivated by mutation or translocation in the myeloid cancers myelodysplastic syndrome and acute myeloid leukemia (AML)3 (∼20% of cases)”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [7]
Citations
Cites
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Altering the Genome by Homologous Recombination
Capecchi, M. R. (1989) · Science · doi:10.1126/science.2660260 · Cited by 1,594
An early haematopoietic defect in mice lacking the transcription factor GATA-2
Tsai, F.-Y., Keller, G., Kuo, F. C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F. W., & Orkin, S. H. (1994) · Nature · doi:10.1038/371221a0 · Cited by 1,237
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Self-citationMiyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732
Erickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631
The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo
Wang, Q., Stacy, T., Miller, J. D., Lewis, A. F., Gu, T.-L., Huang, X., Bushweller, J. H., Bories, J.-C., Alt, F. W., Ryan, G., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81389-6 · Cited by 621
Self-citationGiese, K., Kingsley, C., Kirshner, J. R., & Grosschedl, R. (1995) · Genes & Development · doi:10.1101/gad.9.8.995 · Cited by 541
Research works printed but not linked: 1
- Rowley, J.D. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res. 44, 3159–3168 (1984).
Cited by
Items 201–300 of 344
Direct AKAP-mediated protein-protein interactions as potential drug targets.
Hundsrucker, C., & Klussmann, E. (2008) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-72843-6_20 · Cited by 35
Hug, B. A., Lee, S. Y. D., Kinsler, E. L., Zhang, J., & Lazar, M. A. (2002) · PubMed · Cited by 39
Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8)
Odaka, Y., Mally, A., Elliott, L. T., & Meyers, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203689 · Cited by 36
Runx1 Structure and Function in Blood Cell Development
Bonifer, C., Levantini, E., Kouskoff, V., & Lacaud, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_5 · Cited by 31
ter Elst, A., Ma, B., Scherpen, F. J. G., de Jonge, H. J. M., Douwes, J., Wierenga, A. T. J., Schuringa, J. J., Kamps, W. A., & de Bont, E. S. J. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0402 · Cited by 30
JAK inhibitors suppress t(8;21) fusion protein-induced leukemia
Lo, M.-C., Peterson, L. F., Yan, M., Cong, X., Hickman, J. H., DeKelver, R. C., Niewerth, D., & Zhang, D.-E. (2013) · Leukemia · doi:10.1038/leu.2013.197 · Cited by 31
Self-citationDysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia
Basilico, S., & Göttgens, B. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1535-3 · Cited by 31
A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy
Boyapati, A., Yan, M., Peterson, L. F., Biggs, J. R., Beau, M. M. L., & Zhang, D. (2006) · Blood · doi:10.1182/blood-2006-09-045583 · Cited by 34
Self-citationRoles of RUNX in Hypoxia-Induced Responses and Angiogenesis
Lee, S. H., Manandhar, S., & Lee, Y. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_27 · Cited by 31
Mechanism of ETV6-RUNX1 Leukemia
Sundaresh, A., & Williams, O. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_13 · Cited by 30
Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos
Maki, K., Yamagata, T., Asai, T., Yamazaki, I., Oda, H., Hirai, H., & Mitani, K. (2005) · Blood · doi:10.1182/blood-2004-11-4330 · Cited by 31
Shima, T., Miyamoto, T., Kikushige, Y., Yuda, J., Tochigi, T., Yoshimoto, G., Kato, K., Takenaka, K., Iwasaki, H., Mizuno, S., et al. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.07.267 · Cited by 30
Ben-Aziz, R., Levanon, D., Karn, H. A., Kidron, D., Goldenberg, D., Lotem, J., Polak-Chaklon, S., & Groner, Y. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400415 · Cited by 28
Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective
Hayashi, Y., Harada, Y., & Harada, H. (2022) · Leukemia · doi:10.1038/s41375-022-01548-7 · Cited by 31
Sokol, E. S., Sanduja, S., Jin, D. X., Miller, D. H., Mathis, R. A., & Gupta, P. B. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004161 · Cited by 30
The Role of the AML1 Transcription Factor in Leukemogenesis
Lorsbach, R. B., & Downing, J. R. (2001) · International Journal of Hematology · doi:10.1007/bf02982058 · Cited by 28
Negative effects of GM-CSF signaling in a murine model of t(8;21)–induced leukemia
Matsuura, S., Yan, M., Lo, M., Ahn, E.-Y., Weng, S., Dangoor, D., Matin, M., Higashi, T., Feng, G., & Zhang, D. (2012) · Blood · doi:10.1182/blood-2011-04-350694 · Cited by 29
Self-citationRay, D., Kwon, S. Y., Tagoh, H., Heidenreich, O. T., Ptasinska, A., & Bonifer, C. (2013) · Blood · doi:10.1182/blood-2013-02-482497 · Cited by 28
Murine Models of Acute Myeloid Leukemia
Kurtz, K. J., Conneely, S. E., O'Keefe, M. B., Wohlan, K., & Rau, R. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.854973 · Cited by 29
Thiel, V. N., Giaimo, B. D., Schwarz, P., Soller, K., Vas, V., Bartkuhn, M., Blätte, T. J., Döhner, K., Bullinger, L., Borggrefe, T., et al. (2017) · Leukemia · doi:10.1038/leu.2017.105 · Cited by 26
Developmental-stage-dependent transcriptional response to leukaemic oncogene expression
Regha, K., Assi, S. A., Tsoulaki, O., Gilmour, J., Lacaud, G., & Bonifer, C. (2015) · Nature Communications · doi:10.1038/ncomms8203 · Cited by 27
Loss of RUNX 1/ AML 1 arginine‐methylation impairs peripheral T cell homeostasis
Mizutani, S., Yoshida, T., Zhao, X., Nimer, S. D., Taniwaki, M., & Okuda, T. (2015) · British Journal of Haematology · doi:10.1111/bjh.13499 · Cited by 25
Huang, X., Crute, B. E., Sun, C. C., Tang, Y.-Y., Kelley, J. J., Lewis, A. F., Hartman, K. L., Laue, T. M., Speck, N. A., & Bushweller, J. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2480 · Cited by 25
Self-citationMouse models for core binding factor leukemia
Chin, D. W. L., Watanabe‐Okochi, N., Wang, C. Q., Tergaonkar, V., & Osato, M. (2015) · Leukemia · doi:10.1038/leu.2015.181 · Cited by 23
Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription
Beghini, A. (2019) · Cancers · doi:10.3390/cancers11121973 · Cited by 25
Pahl, M. C., Erdman, R., Kuivaniemi, H., Lillvis, J. H., Elmore, J. R., & Tromp, G. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511229 · Cited by 24
Chee, L. C. Y., Hendy, J., Purton, L. E., & McArthur, G. A. (2012) · Leukemia · doi:10.1038/leu.2012.362 · Cited by 23
Young, D. W., Zaidi, S. K., Furcinitti, P. S., Javed, A., van Wijnen, A. J., Stein, J. L., Lian, J. B., & Stein, G. S. (2004) · Journal of Cell Science · doi:10.1242/jcs.01229 · Cited by 23
Hyde, R. K., & Liu, P. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22596 · Cited by 23
Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1
Taberlay, P. C., James, S. R., Qadi, A. A., West, A. C., Ray, S., Bert, A. G., Cockerill, P. N., & Holloway, A. F. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.03.029 · Cited by 26
Genomic Assessment of Pediatric Acute Leukemia
Mullighan, C. G., Flotho, C., & Downing, J. R. (2005) · The Cancer Journal · doi:10.1097/00130404-200507000-00003 · Cited by 23
Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML
Cammenga, J. (2005) · Leukemia · doi:10.1038/sj.leu.2403894 · Cited by 27
Common gene expression signatures in t(8;21)‐ and inv(16)‐acute myeloid leukaemia
Ichikawa, H., Tanabe, K., Mizushima, H., Hayashi, Y., Mizutani, S., Ishii, E., Hongo, T., Kikuchi, A., & Satake, M. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06310.x · Cited by 24
Mpakou, V., Kontsioti, F., Papageorgiou, S. G., Spathis, A., Kottaridi, C., Girkas, K., Karakitsos, P., Dimitriadis, G., Dervenoulas, I., & Pappa, V. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.10.011 · Cited by 21
cDNA cloning of run, a Caenorhabditis elegans Runt domain encoding gene
Bae, S., & Lee, J. (2000) · Gene · doi:10.1016/s0378-1119(99)00488-6 · Cited by 21
Molecular diagnosis of acute myeloid leukemia
Watt, C. D., & Bagg, A. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.85 · Cited by 22
He, S., Jing, C., & Look, A. T. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2016.11.013 · Cited by 23
ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation
Liu, J., Lu, W., Liu, S., Wang, Y., Li, S., Xu, Y., Xing, H., Tang, K., Tian, Z., Rao, Q., et al. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.02.017 · Cited by 21
Murine Models of Human Acute Myeloid Leukemia
Fortier, J. M., & Graubert, T. A. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-69259-3_11 · Cited by 21
AML1 haploinsufficiency, gene dosage, and the predisposition to acute leukemia
Barton, K., & Nucifora, G. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200003)22:3<214::aid-bies2>3.0.co;2-i · Cited by 20
AML1/ETO–induced survivin expression inhibits transcriptional regulation of myeloid differentiation
Balkhi, M. Y., Christopeit, M., Chen, Y. X., Geletu, M., & Behre, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.05.008 · Cited by 21
The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models
Fisher, J. N., Kalleda, N., Stavropoulou, V., & Schwaller, J. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000152 · Cited by 23
Fusion-protein truncation provides new insights into leukemogenesis
Hess, J. L., & Hug, B. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407898101 · Cited by 19
Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8
Matsushita, H., Kizaki, M., Kobayashi, H., Muto, A., & Ikeda, Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690214 · Cited by 21
AML1/ETO Proteins Control POU4F1/BRN3A Expression and Function in t(8;21) Acute Myeloid Leukemia
Dunne, J., Gascoyne, D. M., Lister, T. A., Brady, H. J. M., Heidenreich, O. T., & Young, B. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3604 · Cited by 19
Rho, J. K., Kim, J. H., Yu, J., & Choe, S. Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02075-2 · Cited by 20
Distinct mechanisms of regulation of the ITGA6 and ITGB4 genes by RUNX1 in myeloid cells
Phillips, J. L., Taberlay, P. C., Woodworth, A. M., Hardy, K., Brettingham‐Moore, K. H., Dickinson, J. L., & Holloway, A. F. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26197 · Cited by 17
Different mutant RUNX1 oncoproteins program alternate haematopoietic differentiation trajectories
Kellaway, S. G., Keane, P., Edginton‐White, B., Regha, K., Kennett, E., & Bonifer, C. (2021) · Life Science Alliance · doi:10.26508/lsa.202000864 · Cited by 17
Silva, N. D., Meyer‐Monard, S., Menot, M.-L., Parrado, A., Lebel, A., Balitrand, N., Fenaux, P., Micléa, J.-M., Rousselot, P. H., Degos, L., et al. (2000) · The Hematology Journal · doi:10.1038/sj.thj.6200047 · Cited by 17
Merghoub, T., Gurrieri, C., Piazza, F., & Pandolfi, P. P. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0385 · Cited by 17
Core binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis
Guo, M., Chan, H. M. T., Zhou, Q., An, Ö., Li, Y., Song, Y., Tan, Z. H., Ng, H. E. V., Peramangalam, P. S., Tan, Z. Q., et al. (2023) · Blood · doi:10.1182/blood.2022015830 · Cited by 24
Self-citationYu, G., Yin, C., Jiang, L., Zheng, Z., Wang, Z., Wang, C., Zhou, H., Jiang, X., Liu, Q., & Meng, F. (2016) · Oncology Reports · doi:10.3892/or.2016.4963 · Cited by 16
Krauter, J., Heil, G., & Ganser, A. (2000) · Hematology · doi:10.1080/10245332.2000.11746532 · Cited by 19
The evolution of cancer modeling: the shadow of stem cells
Vicente‐Dueñas, C., Cobaleda, C., Pérez‐Losada, J., & Sánchez-García, I. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.002774 · Cited by 15
Chromosome Engineering in ES Cells
van der Weyden, L., Shaw-Smith, C. J., & Bradley, A. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-471-1_4 · Cited by 16
Lu, L., Wen, Y., Yao, Y., Chen, F., Wang, G., Wu, F., Wu, J., Narayanan, P., Redell, M. S., Mo, Q., et al. (2018) · Theranostics · doi:10.7150/thno.22800 · Cited by 17
A Hematopoietic-Specific Transmembrane Protein, Art-1, Is Possibly Regulated by AML1
Harada, Y., Harada, H., Downing, J. R., & Kimura, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5005 · Cited by 16
Liu, J., Xing, H., Chen, Y., Wang, L., Wang, D., Rao, Q., Tang, K. J., Tian, Z., He, K., Wang, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.178 · Cited by 13
Mouse Astrocytoma Models: Embryonic Stem Cell Mediated Transgenesis
Ding, H., & Guha, A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012256230365 · Cited by 13
Tumourigenicity of MTG8, a leukaemia‐related gene, in concert with v‐Ha‐ras gene in BALB/3T3 cells
Sueoka, E., Sueoka, N., Okabe, S., Komori, A., Suganuma, M., Kozu, T., & Fujiki, H. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00757.x · Cited by 13
Molecular, Cytogenetic and Genetic Abnormalities in MDS and Secondary AML
Padua, R. A., McGlynn, A., & McGlynn, H. (2001) · Cancer treatment and research · doi:10.1007/978-1-4615-1463-3_8 · Cited by 13
Molecular Diagnosis in Pediatric Acute Leukemias
Bartolo, C., & Viswanatha, D. S. (2000) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30081-7 · Cited by 15
Kellaway, S. G., Chin, P. S., Barneh, F., Bonifer, C., & Heidenreich, O. T. (2020) · Cells · doi:10.3390/cells9122681 · Cited by 11
Pérez-Caro, M., & Sánchez-García, I. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-200-7_1 · Cited by 10
Cell type dependent regulation of multidrug resistance-1 gene expression by AML1-ETO
Hines, R., Boyapati, A., & Zhang, D. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.05.005 · Cited by 10
Self-citationCleavage of AML1/MTG8 by asymmetric hammerhead ribozymes
Szyrach, M., Münchberg, F. E., Riehle, H., Nordheim, A., Krauter, J., Nagel, S., Heil, G., & Heidenreich, O. T. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02259.x · Cited by 10
Myeloid Leukemia, Myelodysplasia, and Myeloproliferative Disease in Children
Clark, J., Berman, J. N., & Look, A. T. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00011-x · Cited by 10
Kugler, E., Madiwale, S., Yong, D., Thoms, J. A. I., Birger, Y., Sykes, D. B., Schmoellerl, J., Drakul, A., Priebe, V., Yassin, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41067-2 · Cited by 9
Kagiyama, Y., Kitaura, J., Togami, K., Uchida, T., Inoue, D., Matsukawa, T., Izawa, K., Kawabata, K. C., Komeno, Y., Oki, T., et al. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1207-6 · Cited by 9
Testa, G., & Stewart, A. F. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd035 · Cited by 8
Evaluation of current mouse in vivo models and advanced in vitro models for leukaemia research
Bubnova, X., Hope, L., & Wheadon, H. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101318 · Cited by 8
Classification of Acute Leukemias: Perspective 1
Ludwig, W.-D., Haferlach, T., & Schoch, C. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-307-1_1 · Cited by 15
Acute Myelomonoblastic Leukemia Carrying the PEBP2β/MYH11 Fusion Gene
Asou, N., Osato, M., Okubo, T., Yamasaki, H. R., Hoshino, K., Nishimura, S., Era, T., Suzushima, H., & Takatsuki, K. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057587 · Cited by 7
Discrimination of target by siRNA: designing of AML1–MTG8 fusion mRNA-specific siRNA sequences
Kasashima, K., Sakota, E., & Kozu, T. (2004) · Biochimie · doi:10.1016/j.biochi.2004.08.003 · Cited by 6
Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis
Peterson, L. F., Lo, M., Okumura, A. J., & Zhang, D. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.06.012 · Cited by 6
Self-citationThe Etiology of Acute Leukemia
Nichol, J. N., Assouline, S. E., & Miller, W. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_14 · Cited by 7
Campana, D., & Pui, C. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00096-5 · Cited by 6
Park, H. J., Lee, K. E., Um, J. M., Choe, S. Y., Chi, X. Z., Lee, J. A., Shin, H. Y., Ahn, H. S., & Bae, S. (2000) · Molecules and Cells · doi:10.1007/s10059-000-0090-9 · Cited by 6
Germline Modification Strategies
Grisendi, S., & Pandolfi, P. P. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc004 · Cited by 6
Dissecting the Molecular Mechanism of Chronic Myelogenous Leukemia Using Murine Models
Ren, R. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000002875 · Cited by 6
C11orf21, a novel RUNX1 target gene, is down-regulated by RUNX1-ETO
Matsumoto, A., Yoshida, T., Shima, T., Yamasaki, K., Tadagaki, K., Kondo, N., Kuwahara, Y., Zhang, D., & Okuda, T. (2022) · BBA Advances · doi:10.1016/j.bbadva.2022.100047 · Cited by 5
Self-citationde Guzman, C. G., Johnson, A., & Klug, C. A. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00025-1 · Cited by 5
Kozu, T., Sugio, Y., Fukuyama, T., Sueoka, E., Otsuka, T., & Akagi, K. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00353.x · Cited by 5
Delaney, C. S., & Bernstein, I. D. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04914.x · Cited by 5
Swoboda, A., Arfelli, V. C., Danese, A., Windisch, R., Kerbs, P., Monte, E. R., Bagnoli, J., Chen-Wichmann, L., Caroleo, A., Cusan, M., et al. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000958 · Cited by 6
Modelling t(8;21) acute myeloid leukaemia ‐ What have we learned?
Chin, P. S., & Bonifer, C. (2020) · MedComm · doi:10.1002/mco2.30 · Cited by 4
Dominant Negative Effects of the AML1/ETO Fusion Oncoprotein
Fenske, T. S., Pengue, G., & Graubert, T. A. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1399 · Cited by 5
Homeobox Gene Expression in Ovarian Cancer
Pando, S., & Taylor, H. S. (2002) · Cancer treatment and research · doi:10.1007/978-1-4757-3587-1_10 · Cited by 4
AML1 and AML1 Fusion Protein AML1-ETO in Myeloid Gene Regulation and Leukemogenesis
Zhang, D., Burel, S. A., Zhou, L., Hetherington, C. J., & Yuan, Y. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0391 · Cited by 5
Self-citationZebrafish as a Model to Characterize TEL2 Function During Development and Cancer
Quintana, A. M. (2012) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s1-001 · Cited by 4
The Etiology of Acute Leukemia
Nichol, J. N., Kinal, M., & Miller, W. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_12 · Cited by 4
RUNX/CBF Transcription Factors☆
Lam, K., & Zhang, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98749-x · Cited by 3
Self-citationNew insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins
Li, J., Guo, C. H., Steinauer, N., & Zhang, J. (2016) · Frontiers in Biology · doi:10.1007/s11515-016-1415-1 · Cited by 4
Campana, D., & Pui, C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50105-6 · Cited by 7
Molecular genetics of acute myeloid leukemia
Lorsbach, R. B., & Downing, J. R. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.012 · Cited by 4
Molecular genetics of acute myeloid leukemia
Gruber, T. A., & Downing, J. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.009 · Cited by 3
T-Cell Development from Hematopoietic Stem Cells
Akashi, K., Kondo, M., Schlageter, A. M., & Weissman, I. L. (1998) · Humana Press eBooks · doi:10.1007/978-1-4757-2778-4_17 · Cited by 3
Genetically Modified Mice in Cancer Research
Largaespada, D. A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-340-2:311 · Cited by 3
Lints, R., Walker, C. A., Delfi, O., Prouse, M., de Silva, M. P., Bohlander, S. K., & Wood, A. (2024) · Biology Open · doi:10.1242/bio.060523 · Cited by 2
MicroRNAs in the midst of myeloid signal transduction
Stoffers, S. L., Meyer, S. E., & Grimes, H. L. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22823 · Cited by 3
Metadata
- Authors
- Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marín-Padilla, M., Tenen, D. G., Speck, N. A., & Zhang, D.-E.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Dartmouth College (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Zhang, Dong-Er
- Venue
- Nature Genetics
- Published
- 1997-03
- Volume
- 15
- Issue
- 3
- Pages
- 303-306
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2054210423
- Cited by
- 346
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 12 · 2016: 4 · 2015: 10 · 2014: 5 · 2013: 7 · 2012: 15
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns022897-10)
- National Cancer Institute (CA 41456, R01CA041456)
- National Institute of Neurological Disorders and Stroke (NS22897)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P030AR42689)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- AML1-ETO fusion gene, acute myeloid leukemia, embryonic lethality, macrophage differentiation, leukemogenesis, CBFB
- MeSH terms
- RUNX1 Translocation Partner 1 Protein, Animals, Chimera, Chromosome Mapping, Chromosomes, Human, Pair 21, Chromosomes, Human, Pair 8, Cloning, Molecular, Crosses, Genetic, DNA-Binding Proteins, Exons, Female, Fetal Death, Hematopoiesis, Genetic Carrier Screening, Humans, Leukemia, Myeloid, Liver, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Proto-Oncogene Proteins, Transcription Factors, Translocation, Genetic, Yolk Sac, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.